Integrated Diagnostics Holdings plc (IDHC.L)

USD 0.34

(4.94%)

Total Liabilities Summary of Integrated Diagnostics Holdings plc

Integrated Diagnostics Holdings plc's latest annual total liabilities in 2023 was 2.66 Billion EGP , down -6.31% from previous year.
Integrated Diagnostics Holdings plc's latest quarterly total liabilities in 2024 Q2 was 3.21 Billion EGP , up 4.62% from previous quarter.
Integrated Diagnostics Holdings plc reported annual total liabilities of 2.84 Billion EGP in 2022, down -17.22% from previous year.
Integrated Diagnostics Holdings plc reported annual total liabilities of 3.44 Billion EGP in 2021, up 96.55% from previous year.
Integrated Diagnostics Holdings plc reported quarterly total liabilities of 3.07 Billion EGP for 2024 Q1, up 15.18% from previous quarter.
Integrated Diagnostics Holdings plc reported quarterly total liabilities of 2.71 Billion EGP for 2023 Q3, up 3.54% from previous quarter.

Annual Total Liabilities Chart of Integrated Diagnostics Holdings plc (2023 - 2012)

Historical Annual Total Liabilities of Integrated Diagnostics Holdings plc (2023 - 2012)

Year	Total Liabilities	Total Liabilities Growth
2023	2.66 Billion EGP	-6.31%
2022	2.84 Billion EGP	-17.22%
2021	3.44 Billion EGP	96.55%
2020	1.75 Billion EGP	25.51%
2019	1.39 Billion EGP	35.04%
2018	1.03 Billion EGP	29.51%
2017	797.72 Million EGP	6.9%
2016	746.21 Million EGP	37.98%
2015	540.82 Million EGP	42.48%
2014	379.58 Million EGP	12.34%
2013	337.89 Million EGP	-9.6%
2012	373.76 Million EGP	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	3.21 Billion EGP	4.62%
2024 Q1	3.07 Billion EGP	15.18%
2023 Q3	2.71 Billion EGP	3.54%
2023 Q4	2.66 Billion EGP	-1.52%
2023 Q1	2.72 Billion EGP	-4.28%
2023 FY	2.66 Billion EGP	-6.31%
2023 Q2	2.61 Billion EGP	-4.01%
2022 Q1	3.7 Billion EGP	7.6%
2022 Q4	2.84 Billion EGP	1.21%
2022 Q3	2.81 Billion EGP	-35.35%
2022 FY	2.84 Billion EGP	-17.22%
2022 Q2	4.35 Billion EGP	17.59%
2021 Q2	2.83 Billion EGP	0.0%
2021 Q4	3.44 Billion EGP	15.1%
2021 Q3	2.99 Billion EGP	5.66%
2021 FY	3.44 Billion EGP	96.55%
2020 Q1	- EGP	-100.0%
2020 FY	1.75 Billion EGP	25.51%
2020 Q4	1.75 Billion EGP	0.0%
2020 Q2	1.28 Billion EGP	0.0%
2019 Q2	1.24 Billion EGP	0.0%
2019 Q4	1.39 Billion EGP	0.0%
2019 FY	1.39 Billion EGP	35.04%
2019 Q1	- EGP	-100.0%
2018 Q3	- EGP	-100.0%
2018 Q1	733.58 Million EGP	-8.04%
2018 FY	1.03 Billion EGP	29.51%
2018 Q4	1.03 Billion EGP	0.0%
2018 Q2	733.58 Million EGP	0.0%
2017 Q2	750.36 Million EGP	0.0%
2017 Q1	750.36 Million EGP	0.56%
2017 FY	797.72 Million EGP	6.9%
2017 Q4	797.72 Million EGP	0.0%
2016 Q4	746.21 Million EGP	0.0%
2016 Q2	516.81 Million EGP	0.0%
2016 FY	746.21 Million EGP	37.98%
2016 Q3	- EGP	-100.0%
2016 Q1	516.8 Million EGP	-4.44%
2015 Q2	435.41 Million EGP	0.0%
2015 FY	540.82 Million EGP	42.48%
2015 Q1	435.41 Million EGP	14.71%
2015 Q4	540.82 Million EGP	0.0%
2014 Q4	379.58 Million EGP	0.0%
2014 Q1	- EGP	-100.0%
2014 FY	379.58 Million EGP	12.34%
2013 FY	337.89 Million EGP	-9.6%
2013 Q4	337.89 Million EGP	0.0%
2012 FY	373.76 Million EGP	0.0%

Peer Total Liabilities Comparison of Integrated Diagnostics Holdings plc

Name	Total Liabilities	Total Liabilities Difference
Revvity, Inc.	5.69 Billion USD	53.1%